Join to View Full Profile
1600 Sw Archer RdGainesville, FL 32610
Phone+1 352-265-0077
Fax+1 352-265-6922
Are you Dr. Cheng?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Xiaodong Cheng, MD is an anesthesiologist in Gainesville, Florida.
Education & Training
University of FloridaResidency, Anesthesiology, 2007 - 2010
Peking Union Medical CollegeClass of 1997
Publications & Presentations
PubMed
- 9 citationsUpdated understanding of the protein-DNA recognition code used by C2H2 zinc finger proteins.Xing Zhang, Robert M Blumenthal, Xiaodong Cheng
Current Opinion in Structural Biology. 2024-08-01 - Protein SUMOylation promotes cAMP-independent EPAC1 activation.Wenli Yang, Fang C Mei, Wei Lin, Mark A White, Li Li
Cellular and Molecular Life Sciences. 2024-07-04 - 4 citationsC2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies.Xing Zhang, Fangfang Xia, Xiaotian Zhang, Robert M Blumenthal, Xiaodong Cheng
Journal of Molecular Biology. 2024-04-01
Press Mentions
Incidence and Risk Factors for Deep Venous Thrombosis of Lower Extremity After Surgical Treatment of Isolated Patella FracturesJanuary 28th, 2021
Coronavirus: A Texas Medical Center Continuing UpdateJuly 28th, 2020- Coronavirus: A Texas Medical Center Continuing UpdateJuly 28th, 2020
Grant Support
- Significance of Epac signaling in renal Na+handling and hypertensionUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2024–2028
- Significance of Epac signaling in renal Na+handling and hypertensionUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2024–2028
- Significance of Epac signaling in renal Na+handling and hypertensionUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2024–2028
- Significance of Epac signaling in renal Na+handling and hypertensionUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2024–2028
- Epac1 as a novel therapeutic target for diabetic retinopathyUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2022–2027
- Epac1 as a novel therapeutic target for diabetic retinopathyUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2022–2027
- Epac1 as a novel therapeutic target for diabetic retinopathyUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2022–2027
- Epac1 as a novel therapeutic target for diabetic retinopathyUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2022–2027
- Epac1 as a novel therapeutic target for diabetic retinopathyUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2022–2027
- Mutual reinforcement between somatic mutations and transcription factors in clonal hematopoiesisTEXAS A&M UNIVERSITY HEALTH SCIENCE CTR2023–2026
- Mutual reinforcement between somatic mutations and transcription factors in clonal hematopoiesisTEXAS A&M UNIVERSITY HEALTH SCIENCE CTR2023–2026
- Preclinical studies of non-nucleoside DNMT3A/3B inhibitorsUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2025
- Preclinical studies of non-nucleoside DNMT3A/3B inhibitorsUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2025
- Preclinical studies of non-nucleoside DNMT3A/3B inhibitorsUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2025
- Preclinical studies of non-nucleoside DNMT3A/3B inhibitorsUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2025
- Epigenetic regulations of DNA and histone methylation and deMethylation: Structures and MechanismsUNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
